Viewing Study NCT05469360


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 12:41 AM
Study NCT ID: NCT05469360
Status: RECRUITING
Last Update Posted: 2025-08-28
First Post: 2022-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module